Xanthic Biopharma Inc. (d.b.a. Green Growth Brands) Announces Name Change to Green Growth Brands Inc. Cannabis Investing News
Innovation Pharmaceuticals Receives New Brilacidin Patent, Further Expanding Intellectual Property Estate Life Science Investing
Sarepta Therapeutics Enters into Long-term Strategic Relationship with Aldevron Life Science Investing
Hemispherx Biopharma Announces Advancement in Expanded Access Program for Ampligen Pharmaceutical Investing
Adamis Pharmaceuticals Submits New Drug Application to FDA for Its Naloxone Pre-Filled Syringe Life Science Investing
U.S. Food and Drug Administration Approves Portola Pharmaceuticals’ Prior Approval Supplement for Andexxa Life Science Investing
